OFF-BRAND GLEEVEC: A AFFORDABLE ALTERNATIVE?

The emergence of off-brand imatinib represents a notable opportunity for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, commonly known as Gleevec, carries a high price tag, frequently presenting a challenge for accessibility for some individuals. Off-